Singapore markets closed

Nuvation Bio Inc. (NUVB)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
2.3900+0.1200 (+5.29%)
As of 09:47AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 488.87M
Enterprise value -210.24M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.71
Enterprise value/revenue N/A
Enterprise value/EBITDA 1.78

Trading information

Stock price history

Beta (5Y monthly) 0.39
52-week change 3-77.37%
S&P500 52-week change 3-15.36%
52-week high 310.4500
52-week low 31.9200
50-day moving average 32.6272
200-day moving average 34.4809

Share statistics

Avg vol (3-month) 3899.51k
Avg vol (10-day) 3624.01k
Shares outstanding 5217.24M
Implied shares outstanding 6N/A
Float 8117.9M
% held by insiders 126.93%
% held by institutions 171.54%
Shares short (14 Sept 2022) 47.82M
Short ratio (14 Sept 2022) 415.33
Short % of float (14 Sept 2022) 49.21%
Short % of shares outstanding (14 Sept 2022) 43.58%
Shares short (prior month 14 Aug 2022) 49.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-9.34%
Return on equity (ttm)-13.94%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -114.47M
Net income avi to common (ttm)-103.26M
Diluted EPS (ttm)-0.4200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)703.8M
Total cash per share (mrq)3.22
Total debt (mrq)4.69M
Total debt/equity (mrq)0.68
Current ratio (mrq)33.58
Book value per share (mrq)3.18

Cash flow statement

Operating cash flow (ttm)-88.48M
Levered free cash flow (ttm)-51.67M